Elevance Health (ELV) Receivables Refunds (2009 - 2019)

Elevance Health (ELV) has 11 years of Receivables Refunds data on file, last reported at $335.0 million in Q4 2019.

• Quarterly Receivables Refunds rose 3250.0% year-over-year to $335.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $335.0 million (up 3250.0% YoY) and the FY2019 annual result came in at $335.0 million, up 3250.0% from the prior year.
• Receivables Refunds grew to $335.0 million in Q4 2019 per ELV's latest filing, from $91.0 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $342.0 million in Q4 2017 and bottomed at $9.0 million in Q2 2016.
• The 5-year median for Receivables Refunds is $154.5 million (2018), against an average of $164.1 million.
• The widest annual swing landed in 2018, when Receivables Refunds slumped 97.08%; it then soared 3250.0% in 2019.
• Tracing ELV's Receivables Refunds over 5 years: stood at $316.6 million in 2015, then tumbled by 46.72% to $168.7 million in 2016, then soared by 102.73% to $342.0 million in 2017, then plunged by 97.08% to $10.0 million in 2018, then soared by 3250.0% to $335.0 million in 2019.
• Per Business Quant, the three latest ELV Receivables Refunds figures stand at $335.0 million (Q4 2019), $91.0 million (Q3 2019), and $296.0 million (Q2 2019).

Peer Comparison